Beta-Amyloid-PET-Bildgebung des Gehirns. DGN-Handlungsempfehlung

Barthel, Henryk; Meyer, Philipp T.; Drzezga, Alexander; Bartenstein, Peter; Boecker, Henning; Brust, Peter; Buchert, Ralph; Coenen, Heinz. H.; Fougere, Christian la; Gründer, Gerhard; Grünwald, Frank; Krause, Bernd J.; Kuwert, Torsten; Schreckenberger, Matthias; Tatsch, Klaus; Langen, Karl-Josef und Sabri, Osama (2016): Beta-Amyloid-PET-Bildgebung des Gehirns. DGN-Handlungsempfehlung. In: Nuklearmedizin-Nuclear Medicine, Bd. 55, Nr. 4: S. 129-137

Abstract

Recently, a number of positron emission tomography (PET) radiotracers have been approved for clinical use. These tracers target cerebral beta-amyloid (AP) plaques, a hallmark of Alzheimer's disease. Increasing use of this method implies the need for respective standards. This German Society of Nuclear Medicine guideline describes adequate procedures for A beta plaque PET imaging. It not only discusses the tracers used for that purpose, but also lists measures for correct patient preparation, image data generation, processing, analysis and interpretation. With that, this "S1" category (according to the German Association of the Scientific Medical Societies standard) guideline aims at contributing to quality assurance of nuclear imaging in Germany.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0029-5566
• Sprache: Deutsch